| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $35.3M | +37.0% |
| SG&A Expense | $4.1M | +57.9% |
| Operating Income | -$39.4M | -38.9% |
| Interest Expense | $2.1M | +66.8% |
| Pre-tax Income | -$40.4M | -36.4% |
| Net Income | -$40.4M | -36.4% |
| EPS (Basic) | -$2.64 | -19.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.6M | -70.8% |
| Short-term Investments | $144.0M | — |
| Current Assets | $175.2M | +105.3% |
| Total Assets | $175.7M | +104.5% |
| Current Liabilities | $6.9M | +174.6% |
| Long-term Debt | $35.8M | +123.8% |
| Total Liabilities | $41.9M | +143.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.0M | -77.3% |
| Capital Expenditures | $159K | +93.9% |
| Investing Cash Flow | -$144.0M | — |
| Financing Cash Flow | $120.3M | +29.3% |
| Free Cash Flow | -$36.2M | -77.3% |
| Stockholders' Equity |
| $133.8M |
| +94.7% |